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Abstract
Purpose: To quantify the effects of motion affected image-derived input functions (IDIF) on the
outcome of tracer kinetic analyses.
Procedures: Two simulation studies, one based on high and the other on low cortical uptake,
were performed. Different degrees of rotational and axial translational motion were added to the
final frames of simulated dynamic positron emission tomography scans. Extracted IDIFs from
motion affected simulated scans were compared to original IDIFs and to outcome of tracer
kinetic analysis (volume of distribution, VT).
Results: Differences in IDIF values of up to 239% were found for the last frames. Patient motion of
more than 6° or 5 mm resulted in at least 10% higher or lower VT values for the high cortical tracer.
Conclusion: The degrees of motion studied are commonly observed in clinical studies and
hamper the extraction of accurate IDIFs. Therefore, it is essential to ensure that patient motion is
minimal and corrected for.
Key words: Patient motion, Motion correction, Positron emission tomography, Image derived
input function, Tracer kinetic analysis
Introduction
T
he quantitative accuracy of positron emission tomog-
raphy (PET) can, among other things, be hampered by
patient motion. This may result in loss of resolution or, more
importantly, affect outcome measures of tracer kinetic
analyses. In general, for tracer kinetic modeling, the time
course of the tracer in arterial plasma (plasma input curve)i s
required, unless a reference tissue, devoid of specific binding
[1, 2], can be found in which non-specific tracer uptake is
identical to that in the tissue of interest. In a previous
simulation study, it was shown that errors in the outcome of
tracer kinetic analyses could be as high as 45% when a
motion of 2 cm was present [3]. In the same study, an offline
frame-by-frame motion correction method was introduced,
which accurately corrected PET scans for patient motion [3].
This previous study only took into account effects of motion
on determining radioactivity concentrations in the tissue of
interest, as arterial sampling was used to obtain the plasma
input curve. Obviously, arterial sampling is not affected by
patient motion, but it is an invasive and laborious procedure.
In addition, arterial sampling is sensitive to errors and has a
small risk of adverse effects [4, 5]. To overcome the
problems of arterial sampling, many alternative methods
have been proposed [6]. In previous studies, such an
alternative method was developed [6] and validated [7, 8],
in which input functions were extracted from the dynamic
PET scan itself, thereby obviating the need for arterial
sampling. Although these image-derived input functions
(IDIFs) do not have the disadvantages of arterial sampling,
they are vulnerable to patient motion [6, 8]. To extract an
IDIF, amaskover the internal carotidarteries can bedefined in a
summed image of the first couple of frames. This mask is then
copied to all dynamic frames to derive the IDIF. Patient motion
in later frames, however, will result in under- or overestimation
of IDIF values and, therefore, in inaccurate IDIFs. The under-
and overestimation of IDIF values in motion affected frames are
not just due to the mislocation of the IDIF mask, but also due to
an erroneous attenuation correction. These inaccurate IDIFs in
turn will affect the outcome of tracer kinetic analyses. Correspondence to: Ronald Boellaard; e-mail: r.boellaard@vumc.nlThe purpose of the present study was to quantify the
effects of motion on the outcome of tracer kinetic analyses
whenIDIFsaffected bythatmotion areusedasinputfunction.
Tothisend, simulation studieswere performed based on[
11C]
flumazenil and (R)-[
11C]verapamil kinetics, thereby inves-
tigating effects for both high and low cortical uptake tracers.
Materials and Methods
Simulated PET Scans
Two simulated scans were generated, one simulating [
11C]fluma-
zenil kinetics, the other (R)-[
11C]verapamil. These two tracers were
chosen, as they represent examples of high and low cortical uptake
tracers, respectively. Both simulated PET scans were based on a
grey-white matter segmented magnetic resonance imaging (MRI)
scan. For each tracer, typical grey and white matter time activity
curves (TACs) were allocated to the grey and white matter
segmentations of the MRI scan, respectively. Finally, these grey
and white matter segmentations were summed, generating a
simulated dynamic emission scan with the following frames:
▪ [
11C]flumazenil: 4×15, 4×60, 2×150, 2×300, 4×600 s;
▪ (R)-[
11C]verapamil: 1×15, 3×5, 3×10, 2×30, 3×60, 2×
150, 2×300, 4×600 s.
In addition, the internal carotid artery was simulated by
allocating whole blood TAC (not corrected for metabolites) from
actual human [
11C]flumazenil and (R)-[
11C]verapamil subjects to
the segmented carotid artery and circle of Willis as seen on the
MRI scan. Finally, simulated PET scans were smoothed with a
Gaussian kernel of 6 mm to obtain a resolution comparable to that
of current PET scanners.
Simulated Motion
Before adding motion to the simulated PET scans, the simulated
scans were forward projected to obtain sinograms and the
inverse attenuation correction, derived from a reconstructed
transmission scan, was applied to these sinograms. Next, these
sinograms were reconstructed using a normalization weighted
ordered subsets expectation maximization (OSEM) to generate
non-attenuation corrected images.
Two types of motion were imposed onto the non-attenuation
corrected simulated scans. First, different degrees of rotation
(napping/nodding, 1, 3, 4, 6, 7, 8, 10, 12, and 15°, corresponding
to ∼2-20 mm) were applied. The second type of motion simulated
an axial inferior movement (1-6, 10, 15, and 20 mm) of the subject.
These movements are seen most frequently in clinical practice in
case subjects are fixed using a head holder. In addition, the range of
rotational and translational movements corresponds with those
observed in clinical practice [9, 10]. Motion was added using Vinci
software (Max Planck Institute for Neurological Research,
Cologne, Germany, http://www.mpifnf.de/vinci/). As motion is
most frequently observed at later time points (910 min p.i.) [11]i n
this simulation, it was only added to the last six frames of each
simulated scan. The motion was, however, simulated as a gradual
phenomenon, according to the following scheme, where N
represents the total number of frames:
 Frame N-5: 10% of maximum motion,
 Frame N-4: 25% of maximum motion,
 Frame N-3: 40% of maximum motion,
 Frame N-2: 60% of maximum motion,
 Frame N-1: 75% of maximum motion,
 Frame N: maximum motion.
After adding motion, all non-attenuation corrected simulated
PET scans were again forward projected to obtain sinograms. These
sinograms were then reconstructed using normalization and
attenuation weighted OSEM to obtain standard dynamic PET
images. All reconstructions were performed using four iterations
and 18 subsets and consisted of 63 planes of 128×128 voxels and a
voxel size of 2.57×2.57×2.43 mm
3.
Image Derived Input Functions
Toextract an IDIF, a region of interest(ROI) was definedon a volume
of 14 successive planes, starting six planes below the circle of Willis.
This volume corresponded to the position of the carotid arteries. The
IDIF ROIs were defined (semi)-automatically on frame 3 of the
original (unmoved) simulated scan using the ‘four hottest pixels per
plane’ method [6]. These ROIs were projected onto all frames of the
simulated scan thereby generating image-derived whole blood time
activity curves. Image-derived whole blood time activity curves were
corrected for metabolites and plasma-to-whole blood ratios by use of
plasma-to-whole blood and parent fractions derived from seven
manual samples, as described previously [6–8], resulting in parent
plasma IDIFs. The procedure for extracting IDIFs was repeated for all
simulated PET scans using the original IDIF mask.
Analysis
IDIFs that were extracted from scans with superimposed move-
ments were compared with original (unmoved) IDIFs. In addition,
for each scan, parametric volume of distribution (VT) images were
calculated using Logan analysis [12]. To determine the overall
effect of motion on outcome of tracer kinetic analyses, VT images
were calculated from motion affected scans, together with IDIFs
extracted from those scans. In addition, to determine the specific
effects of motion-affected IDIFs alone, VT images were also
calculated using those IDIFs in combination with the original scans
(i.e., without superimposed movement) to show effects of motion
artefacts in IDIFs only. Resulting mean VT values for different
anatomical regions (frontal, prefrontal, temporal, occipital cortex,
parietal cortex, thalamus, caudate, cerebellum, and pons) were
calculated and compared with original VT values. Results are
presented as mean percentage differences (mean ± SD) over all
regions between original (unmoved) and motion-affected scans.
In addition, all simulated PET scans were corrected for
motion using a frame-by-frame motion correction method.
Motion correction was performed using the Automated Image
Registration (version 5.1.5; [13]) with optimal settings, as found
in a previous study [3]. For (R)-[
11C]verapamil, optimal settings
of (R)-[
11C]PK11195 were used, as (R)-[
11C]verapamil is also a
26 J.E.M. Mourik et al.: IDIFs: Effects of Motionlow cortical uptake tracer. After motion correction, new IDIFs
were extracted and corrected for metabolites and plasma-to-
whole blood ratios. VT images were generated using the motion-
corrected simulated PET scans and the new IDIFs. Mean VT
values were again compared to the original VT values.
Results
IDIF Extraction
To illustrate the problem of extracting IDIFs in case of
motion, examples of IDIF masks projected onto scans
affected by different degrees of rotational and translational
motion are shown in Figs. 1 (sagittal view) and 2 (coronal
view), respectively. It can be seen that, in this example,
mispositioning of the mask (black region, indicated with
the arrow) becomes problematic when there is a translation
of at least 3° (Fig. 1) or a rotation of at least 4 mm
(Fig. 2). For the largest movements (at least 6° or 10 mm),
the IDIF mask actually is, at least in part, positioned within
the brain and this may result in both under- or over-
estimation of the IDIF depending on relative blood and
tissue concentrations.
Effect of Motion on IDIF
Figure 3 shows the last part (98 min) of IDIFs extracted
from the original simulated scans (3a, b: [
11C]flumazenil; 3c,
d: (R)-[
11C]verapamil) together with IDIFs extracted from
scans that were affected by different degrees of translational
(Fig. 3a, c) and rotational (Fig. 3b, d) motion. Note that the
first part is not shown in Fig. 3, as no motion was imposed
onto the first couple of frames (0-10 min). For [
11C]
flumazenil-based simulations, large differences (up to
205% in the final frame) in IDIF values were found in case
of a rotational movement of 15°. For rotational movements
of 3° or less, differences were smaller than 10%. When
translational motion was present, differences of up to 68%
(10 mm) and 239% (20 mm) in IDIF values were seen. For
translational motions smaller than 4 mm, overestimation of
IDIF values was 10% or less. For (R)-[
11C]verapamil-based
simulations, large differences in IDIF values were seen for a
rotational movement of 6° and a translational movement of
3 mm (both up to 19% higher IDIF values). In case of smaller
movements, only differences of up to 13% were found.
Maximal differences in IDIF values for (R)-[
11C]verapamil
were found for a rotational movement of 15° (up to 91%) and
a translational movement of 20 mm (up to 154%).
Effect of Motion-affected IDIFs on Tracer Kinetic
Analysis
Regional differences between original VT and VT derived
from motion-affected PET scans in combination with
motion-affected IDIFs for [
11C]flumazenil and (R)-[
11C]
verapamil are shown in Figs. 4 and 5, respectively. For
[
11C]flumazenil, largest regional differences (maximal 59%)
are found for the putamen and caudate (both rotational and
translational, Fig. 4a, b) and thalamus (Fig. 4a). Mean
differences in VT values over all regions are shown in
Table 1. On average over all regions, differences 910% were
found for a motion of 6° (12%) or at least 5 mm (10%). For
(R)-[
11C]verapamil-based simulations, no large regional
differences were found (Fig. 5a, b). On average, differences
910% were observed for a rotational motion of 12° and a
translational motion of 4 mm (Table 1).
The specific effect of (only) mislocating IDIFs them-
selves is shown in Table 2. For all anatomic regions nearly
the same differences were found (note the low SD values in
Table 2). As expected, mean differences over all regions
increased with increasing degree of motion. For (R)-[
11C]
verapamil-comparable results were obtained compared to the
general effect of motion in case both motion-affected IDIF
and motion-affected dynamic PET scans (Table 1) were
used. For [
11C]flumazenil, the same, but lower trend was
observed compared to the general effect of motion (Table 1).
Tracer Kinetic Analysis After Motion Correction
Mean differences between original VT and VT derived from
motion corrected-PET scans in combination with IDIFs
extracted from those motion corrected PET scans are shown
in Table 3. For [
11C]flumazenil, only very small differences
Fig. 1. Sagittal view of the last frame of the [
11C]flumazenil simulated PET scan with on top the IDIF mask (black region,
indicated with arrow in top left image) generated using the four hottest pixels per plane method. The simulated PET scan has
different amounts of rotational movement.
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1.4±0.6%). However, somewhat larger differences were
found for (R)-[
11C]verapamil (maximal 4.3±0.5%).
Discussion
Simulated Motion
Both rotational and translational motions were added to the
simulated scans, as these are the most frequently observed
types of patient motions [9]. Although the amount of patient
motion is generally small, for some patient groups (i.e.,
Alzheimer, Parkinson, or neurotrauma) motion up to 20-
30 mm has been observed [3, 9, 10].
Effect of Motion on IDIF
Although the IDIF mask was (in part) positioned outside the
carotid artery for a translational motion of 4 mm or a
rotational motion of at least 3°, large differences in IDIF
values were only observed for a translational motion of at
Fig. 3. IDIFs (10–60 min, mid frame times are shown on x-axis) extracted from simulated [
11C]flumazenil (a, b) and (R)-[
11C]
verapamil (c, d) scans with superimposed translational (a, c), and rotational (b, d) movements at later time frames.
Fig. 2. Coronal view of the last frame of the [
11C]flumazenil simulated PET scan with on top the IDIF mask (black regions,
indicated with two arrows in top left image) generated using the four hottest pixels per plane method. The simulated PET scan
has different amounts of translational movement.
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(Fig. 3b). The same trend was observed for (R)-[
11C]
verapamil-based simulations, but differences were in general
lower (Fig. 3c, d) .T h ed i f f e r e n c eb e t w e e nt h e s et w o
simulation studies is due to the difference in cortical uptake
of both tracers. For large movements (10 mm or 96°), the
IDIF mask is (primarily) positioned within cortical brain
regions. For [
11C]flumazenil, with high cortical uptake, this
results in higher IDIF values (Fig. 3a, b). In contrast, for (R)-
[
11C]verapamil, with low cortical uptake, only slightly
higher IDIF values were found (Fig. 3c, d), except for the
largest motion added. Note, however, that movements in
other directions may result in different effects.
Effect of Motion-affected IDIF on Tracer Kinetic
Analysis
In a previous study, it was shown that motion has major
impact on the outcome of tracer kinetic analyses [3]. Those
results, however, were obtained using a (simulated) arterial
input function derived from arterial sampling (i.e., not
affected by motion). In the present study, IDIFs were
obtained from motion-affected PET scans. Again, potentially
large errors in VT values were seen (Figs. 4 and 5, Table 1).
In practice, patient motion affects the entire scan, i.e.,
both tissue TACs and the corresponding IDIF. To assess the
specific effects of erroneous IDIFs (due to motion), VT
images were also generated using motion-affected IDIFs
together with original (unmoved) PET images. In general,
differences in VT values (Table 2) were comparable to
differences in VT values when motion-affected IDIF were
used together with the motion-affected PET images
(Table 1). Therefore, it can be concluded that differences
in VT values are mainly due to the mislocation of the IDIF
mask as a result of the motion during the dynamic scan.
In general, small motions of up to 2 mm or 3° had little
effect (maximum 5.4%) on VT when only motion-affected
IDIFs were taken into account. In fact, overall effects on VT
were even larger than in previous report, where only tissue
data were affected by motion [3]. However, as mentioned
before, IDIFs are extracted from the carotid artery up to at
most the base of skull. This region might be less affected by
Fig. 4. [
11C] flumazenil derived VT errors for different
anatomic regions and different amounts of (a) translational
and (b) rotational added motion.
Fig. 5. (R)-[
11C] verapamil derived VT errors for different
anatomic regions and different amounts of (a) translational
and (b) rotational added motion.
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head. Therefore, the results in this paper likely overestimate
the effects of motion on pharmacokinetic outcome. In
general, it is always recommended to make sure that patient
motion is minimal (e.g., by using a head restraint) and, if
necessary, to quantify the amount of motion and correct
dynamic PET data for patient motion, either using an online
optical tracking system [10, 14] or using an offline frame-
by-frame motion correction method [3].
Tracer Kinetic Analysis After Motion Correction
Motion correction improved the accuracy of tracer kinetic
analysis for both simulation studies. However, there were
some differences in outcome of the motion correction
between the two simulation studies. For [
11C]flumazenil
only very small differences in VT values were found
(Table 3), indicating that motion correction was very
accurate. On the other hand, much larger differences in VT
values were found after correcting the (R)-[
11C]verapamil
scans for motion. In general, for (R)-[
11C]verapamil, motion
correction improved outcome in tracer kinetic analysis,
except for the smallest rotational movement (1° and 3°).
The difference in performance of the motion correction
method may be explained by the difference in uptake
between both tracers. (R)-[
11C]verapamil is a low cortical
tracer, and therefore those scans have much less contrast,
which makes it more difficult for the motion correction
method to find the optimal match. [
11C]flumazenil is a high
cortical tracer and therefore co-registration might be more
precise. Nevertheless, it is shown that motion correction
already improved accuracy of tracer kinetic analysis for both
tracers studied.
Additional Remarks
In this simulation study, it was assumed that there was no
patient motion in the first 10 min of the scan and motion was
superimposed only on the final part of the scan (10–60 min).
Although this is by far the most frequently observed motion
in clinical practice, patient motion during the early frames of
a dynamic PET scan can occur. It is likely that motion
during these early frames, where the IDIF mask is defined,
will have an even larger impact on outcome of tracer kinetic
analyses. It is therefore recommended to always check for
any motion (e.g., by making movies [3]) and to perform a
quality check on the derived IDIFs (e.g., by calculating the
peak-to-tail ratio as described previously [6]).
In the present study, IDIFs were extracted from simulated
standard OSEM reconstructed images. To obtain accurate
Table 1. Mean VT errors (±SD%) over different anatomic regions derived
from motion-affected simulated PET scans in combination with IDIFs
extracted from the same motion-affected scans
Motion VT error (%)
[
11C]flumazenil
VT error (%)
(R)-[
11C]verapamil
Translation (mm) 1 2.2±0.9 2.7±0.2
2 4.2±1.8 5.3±0.4
3 6.2±2.7 7.7±0.6
4 8.3±3.7 10.1±0.7
5 10.3±4.8 12.3±0.8
6 12.3±6.0 14.5±0.9
10 20.7±10.2 23.3±1.4
15 39.5±10.6 33.4±1.8
20 40.6±12.9 41.1±1.8
Rotation (deg) 1 1.4±0.6 0.4±0.2
3 5.0±2.0 0.9±0.5
4 7.1±2.9 1.1±0.6
6 11.9±5.3 2.5±1.2
7 14.4±6.6 3.8±1.8
8 17.2±7.8 5.5±2.2
10 22.7±9.2 9.7±2.7
12 28.2±10.3 14.5±3.1
15 35.6±11.2 21.7±3.4
Table 3. Mean VT errors (±SD%) over different anatomic regions derived
from motion-affected simulated PET scans after motion correction
Motion VT error (%)
[
11C]flumazenil
VT error (%)
(R)-[
11C]verapamil
Translation (mm) 1 0.4±0.2 1.1±0.2
2 0.6±0.4 1.9±0.3
3 1.1±0.4 3.0±0.4
4 1.0±0.4 4.3±0.5
5 0.9±0.4 0.6±0.3
6 0.9±0.5 2.6±0.5
10 1.4±0.4 0.6±0.3
15 1.4±0.6 2.5±0.5
20 1.3±0.6 2.4±0.6
Rotation (deg) 1 0.4±0.3 0.7±0.2
3 0.8±0.4 1.0±0.6
4 0.7±0.3 0.9±0.6
6 1.2±0.6 1.6±0.7
7 1.2±0.6 2.3±1.1
8 1.3±0.6 3.3±1.7
10 1.0±0.6 1.7±0.8
12 1.0±0.6 1.5±1.1
15 1.0±0.6 3.4±0.5
Table 2. The specific effect of motion-affected IDIFs on outcome of tracer
kinetic analysis. Mean VT differences (mean ± SD%) over different anatomic
regions derived from original (no motion) simulated PET scans in combination
with IDIFs extracted from motion-affected simulated PET scans
Motion VT error (%)
[
11C]flumazenil
VT error (%)
(R)-[
11C]verapamil
Translational (mm) 1 1.0±0.0 2.7±0.0
2 1.9±0.0 5.4±0.0
3 2.7±0.0 7.8±0.1
4 3.7±0.0 10.2±0.1
5 4.6±0.0 12.4±0.1
6 5.6±0.0 14.6±0.1
10 11.0±0.0 23.2±0.1
15 30.2±0.0 32.8±0.2
20 30.2±0.0 40.6±0.2
Rotation (deg) 1 0.1±0.0 0.1±0.0
3 1.7±0.0 0.6±0.0
4 3.0±0.0 1.4±0.0
6 6.4±0.0 3.6±0.0
7 8.5±0.0 5.2±0.0
8 10.8±0.0 7.1±0.0
10 15.5±0.0 11.2±0.1
12 20.4±0.0 15.8±0.1
15 27.5±0.0 22.5±0.1
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scans for partial volume effects, e.g., by using a reconstruc-
tion-based partial volume correction (PVC) method [6, 7].
Although more accurate IDIFs are obtained from PVC
scans, they also are more affected by motion. This is due
to the fact that the carotid arteries are spatially more
confined than in standard reconstructed images. The
carotid artery is therefore more easily positioned outside
the IDIF mask. Partial volume effects are especially
important in early frames, which are associated with large
differences in activity concentrations between blood and
soft tissue. However, for later frames, activity concen-
trations of blood and soft tissue are more comparable and
therefore effects of PVC will be much lower than for
early frames. In the present study, motion was applied
only to the last six frames and therefore additional effects
of PVC were low. However, these effects may be much
higher when motion is present in the early frames. Yet,
this paper already shows that motion can severely affect
the quantitative accuracy of IDIFs.
Image noise may affect the accuracy of IDIFs and may
therefore have a negative effect on the outcome of tracer
kinetic analysis. In the present study, no noise was simulated
because the aim was to quantify the net effects of motion on
extracting IDIFs and the resulting effects on subsequent
tracer kinetic analysis. Noise in IDIFs may result in an
additional reduction in accuracy of tracer kinetic analysis,
but this will also be the case if no motion is present.
Therefore, further studies are needed to assess the differ-
ential effects of noise.
In the present study, both whole brain and the neck were
rotated. In clinical practice, the neck is supported and
therefore it will be less affected by rotational motion than
the brain. Consequently, errors in VT due to rotational
motion (e.g. 6°) were for this study somewhat larger (11.9±
5.3%) than for a previous study (6.7±5.3%) where the effect
of motion on determining radioactivity concentrations in the
tissue of interest was taken into account, as arterial sampling
was used to obtain the plasma input curve [3]. For transla-
tional motion (e.g. 4 mm), errors in VT due to motion
artefacts in tissue TAC were 2.9±2.5% as shown in a
previous study [3] and 8.3±3.7% due to motion artefacts in
IDIFs as shown in this study.
The present study was performed using tracers with high
([
11C]flumazenil) and low ((R)-[
11C]verapamil) cortical
uptake, thereby representing tracers having substantial
different kinetics. Therefore, to some extent, results may be
applicable to other tracers, but it should be validated for each
tracer independently.
Conclusion
Extraction of IDIFs from motion-affected dynamic emission
scans led to over- or underestimation of VT values even in
the case of small patient motion (5 mm or 6°). Therefore,
when IDIFs are used, it is essential to ensure that patient
motion is minimal and that dynamic PET data are corrected
for patient motion.
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